The diagnostics advisory committee reviewed the evidence available on the clinical and cost effectiveness of epidermal growth factor receptor tyrosine kinase (EGFR‑TK) mutation testing to inform first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback